FGen is an emerging Swiss company that combines biological engineering, such as synthetic biology, metabolic engineering, or non-GMO methods, with high throughput screening to design and optimize cells for biotechnological applications. Key to this process is FGen's proprietary nonoliter-reactor (NLR) platform that enables the phenotypic screening of cell libraries at rates of more than 1 million clones per day, thereby surpassing multi-well plate systems by orders of magnitude. The NLR technology enables analysis under relevant conditions (e.g. fed-batch cultivation, defined environments) and has successfully be used for production of small molecules and proteins by bacteria, yeast, fungi, and mammalian cells.
FGen uses its expertise in biological engineering and high throughput screening in collaboration with industrial partners in industrial biotech, life sciences and pharma to develop products for various markets.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Hochbergerstrasse 60c, Basel,other 4057,switzerland
- Phone
- +41 61 633 29 20
- in****@****FGen.ch
- Industry
- Biotechnology
- Website
- fgen.ch
- Keywords
- Synthetic biology, Strain development, High throughput screening, Industrial biotechnology, Metabolic engineering, Protein engineering, Microbiome, Bacteria, Yest, Fungi, non-GMO.
- HQ
- Basel, Other
Fgen Questions
Fgen's helpline number is +41 61 633 29 20
Fgen's website is fgen.ch
Fgen's LinkedIn profile is https://ch.linkedin.com/company/fgen
Fgen has
12 employees.
View email and phone details for 12
employees at Fgen.
Fgen's industry is
Biotechnology
Fgen's top competitors are
Pharmabiome Ag,
Incephalo,
Lucid Analytics,
Syngenta,
Swiss Rockets Ag,
Fibrogen, Inc.,
Myria Biosciences Ag,
Spirochem,
First Gen Corporation,
Ginkgo Bioworks, Inc..
Fgen's support email address is info@FGen.ch
Fgen's categories are Biotechnology
Fgen's founding year is 2011
